Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Akari Therapeutics, Plc
London, United Kingdom
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 31, 2017, relating to the consolidated financial statements of Akari Therapeutics, Plc. appearing in the Company’s Annual Report on Form 20-F for the year ended December 31, 2016.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP | |
New York, New York | |
February 21, 2018 |